Article Versions Notes

Tupini C, Zurlo M, Gasparello J, Lodi I, Finotti A, Scattolin T, Visentin F, Gambari R, Lampronti I. Combined Treatment of Cancer Cells Using Allyl Palladium Complexes Bearing Purine-Based NHC Ligands and Molecules Targeting MicroRNAs miR-221-3p and miR-222-3p: Synergistic Effects on Apoptosis. Pharmaceutics. 2023; 15(5):1332. https://doi.org/10.3390/pharmaceutics15051332

Tupini, Chiara, Matteo Zurlo, Jessica Gasparello, Irene Lodi, Alessia Finotti, Thomas Scattolin, Fabiano Visentin, Roberto Gambari, and Ilaria Lampronti. 2023. "Combined Treatment of Cancer Cells Using Allyl Palladium Complexes Bearing Purine-Based NHC Ligands and Molecules Targeting MicroRNAs miR-221-3p and miR-222-3p: Synergistic Effects on Apoptosis" Pharmaceutics 15, no. 5: 1332. https://doi.org/10.3390/pharmaceutics15051332

Tupini, C., Zurlo, M., Gasparello, J., Lodi, I., Finotti, A., Scattolin, T., Visentin, F., Gambari, R., & Lampronti, I. (2023). Combined Treatment of Cancer Cells Using Allyl Palladium Complexes Bearing Purine-Based NHC Ligands and Molecules Targeting MicroRNAs miR-221-3p and miR-222-3p: Synergistic Effects on Apoptosis. Pharmaceutics, 15(5), 1332. https://doi.org/10.3390/pharmaceutics15051332